October 20, 2014 7:41 AM ET

Pharmaceuticals

Company Overview of Verus Pharmaceuticals, Inc.

Executive Profile

Jean-Pierre Naegeli

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Mr. Jean-Pierre Naegeli was a Partner at Paul Capital Partners. He served in the same position at Paul Capital Healthcare. Mr. Naegeli joined Paul Capital in 2000 and was based at the New York office. He focused on sourcing and structuring royalty transactions and leading the Paul Royalty Fund’s and Paul Capital Healthcare’s overall due diligence efforts in healthcare. Mr. Naegeli previously served as a Principal at the firm. Prior to that, he spent nearly ten years ...

Corporate Headquarters

12671 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-436-1600
Fax: 858-436-1601

Board Members Memberships

Director
Director

Education

MS
Eidgenössische Technische Hochschule Zürich
BS
Eidgenössische Technische Hochschule Zürich
MBA
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Verus Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.